PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer
Clinical trial NCT05035381 · UNKNOWN
Trial details
- NCT number
- NCT05035381
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2022-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.